Your Health, We Care
Release date: 2024-07-10 14:49:13 Recommended: 117
TABRECTA is suitable for treating adult patients with metastatic non-small cell lung cancer (NSCLC), whose tumors have mutations that lead to a jump in exon 14 of mesenchymal epithelial transition (MET) according to FDA approved testing. MET gene mutation is one of the rare mutations in lung cancer, including MET14 jump mutation (3%) and MET amplification (1%).
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：208Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：221Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：193Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：159Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：291Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：171Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：326Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：197Release date: 2024-07-09
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) ···【more】
Recommended：155Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the man···【more】
Recommended：152Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Fo···【more】
Recommended：168Release date: 2024-12-30
The new indication involves the treatment of adult patients with locally advance···【more】
Recommended：158Release date: 2024-12-24
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont···【more】
Recommended：144Release date: 2024-12-17
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-C···【more】
Recommended：104Release date: 2024-12-13
